Clinical Trials Directory

Trials / Completed

CompletedNCT02120105

Cystine Capacity Clinical Study (CysCap)

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
8 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether urinary cystine capacity, an assay used to measure the amount of cystine in the urine, can be used to predict stone recurrence in patients with cystinuria.

Detailed description

Cystinuria is a rare genetic cause of kidney stones that leads to significant morbidity due to the recurrent nature of the disease. Despite recent advancements in knowledge about cystinuria, such as the discovery of the genetic defects that cause the disease, there have been very few studies of clinical determinants of recurrent stone formation. An optimal method of measuring cystine solubility in the urine has been lacking, and therefore response to pharmacologic and dietary therapy is often not known. Recently, a new assay to measure the amount of cystine in the urine was developed called Cystine Capacity, or CysCap. It is an assay that adds a pre-formed amount of cystine crystals to urine and measures the amount of cystine the urine can take up from the solid phase (in undersaturated urine) or gives up to solid phase (in supersaturated urine). This study seeks to examine how well this measure of urinary cystine predicts stone occurrence, with the ultimate goal of helping to guide therapy and preventing kidney stones in cystinurics. This is an observational study over 3 years. Subjects who are enrolled in the study will perform semi-annual 24-hour urine collections. They will undergo imaging of the kidneys every 6 months to monitor kidney stone formation or growth, in order to correlate urinary parameters with clinical events. The study will examine how well the urinary cystine capacity predicts stone formation.

Conditions

Timeline

Start date
2012-09-01
Primary completion
2017-02-24
Completion
2017-02-24
First posted
2014-04-22
Last updated
2018-12-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02120105. Inclusion in this directory is not an endorsement.